Neutral
Biotech stocks boost ALPS Medical Breakthroughs ETF (SBIO) with 18.7% gain in June, driven by key drug trials and buyout.
The ALPS Medical Breakthroughs ETF (SBIO) saw an impressive 18.7% return in June, spurred by significant developments in biotech stocks. This surge wa...